Biotech Distilled

Recent Posts

DEEP DIVE: Biotech Distilled Top 25 Therapy Types - siRNAs

Therapy Type Rank: 3/25

The Biotech Distilled Top 25 Therapy Types in Biotech for 2026

Where to Fish in 2026

The Biotech Distilled Top 5 Conviction List — April 2026

Scynexis, Inc. (SCYX) - Scientific Deep Dive for SCY-770 (ADPKD) and Pipeline Products

From NASH Reject to Kidney Hopeful: An Orphaned AMPK Activator Walks Into Novartis’s Shark Tank

The Biotech Distilled Buy/Sell/Watch List

Under The Radar Biotechs With Asymmetric Potential

UPDATE: Wave Life Sciences (WVE) - The Smart Money Just Faded the Retail Panic

UPDATE: Spyre Therapeutics (SYRE) – Q1 2026 Status Check

Counsel Signals — March 29 – April 12, 2026

UPDATE: Agomab Therapeutics (AGMB) - The FDA Just Blessed the Right Endpoint

UPDATE: Nuvectis Pharma (NVCT) - The One-Asset Company Just Bought Two More

UPDATE: Janux Therapeutics (JANX) - The CMO Walks After Six Months

UPDATE: Enanta (ENTA) - The Federal Circuit Tore Up One of the Lottery Tickets

Relmada Therapeutics (RLMD) — Scientific Deep Dive for NDV-01 and Sepranolone

UPDATE: Allogene Therapeutics (ALLO) - The ATM Arrives Two Months Early

UPDATE: Arvinas (ARVN) - The CMO Walks Three Weeks Before the Catalyst Window Opens